Results 1 to 10 of about 40,431 (264)
Proceedings of the Royal Society of Medicine, 1962
J S Pegum, Patricia Wallis
openalex +3 more sources
J S Pegum, Patricia Wallis
openalex +3 more sources
Blood, 2022
Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary (smoking-associated), or multisystem disease.
G. Goyal+17 more
semanticscholar +1 more source
Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary (smoking-associated), or multisystem disease.
G. Goyal+17 more
semanticscholar +1 more source
Blood, 2021
ALK-related histiocytosis (formerly ALK-positive histiocytosis) is a rare subtype of histiocytic neoplasm first described in 2008 in three infants with multisystemic disease involving the liver and hematopoietic system.
P. Kemps+80 more
semanticscholar +1 more source
ALK-related histiocytosis (formerly ALK-positive histiocytosis) is a rare subtype of histiocytic neoplasm first described in 2008 in three infants with multisystemic disease involving the liver and hematopoietic system.
P. Kemps+80 more
semanticscholar +1 more source
Progress in the diagnosis and treatment of ocular histiocytosis [PDF]
Guoji Yanke Zazhi, 2023Ocular histiocytosis is a rare and heterogeneous group of disorders which can occur in children and adults. There is a great challenge in the diagnosis and treatment because of the atypical clinical and imaging manifestations.
Jun-Yi Qiao, Wei-Min He
doaj +1 more source
Langerhans cell histiocytosis in adults: literature review
Онкогематология, 2022Langerhans cells histiocytosis is a variant of malignant histiocytosis. The course and symptoms vary. patients with localized forms have a better prognosis, because local therapy is effective.
V. G. Potapenko+3 more
doaj +1 more source
Histiocytosis and the nervous system: from diagnosis to targeted therapies
Neuro-Oncology, 2021Histiocytoses are heterogeneous hematopoietic diseases characterized by the accumulation of CD68(+) cells with various admixed inflammatory infiltrates.
F. Cohen Aubart+7 more
semanticscholar +1 more source
Langerhans cell histiocytosis: Version 2021
Hematological Oncology, 2021Children with Langerhnans cell histiocytosis (LCH) develop granulomatous lesions with characteristic clonal CD207+ dendritic cells that can arise as single lesions or life‐threatening disseminated disease. Despite the wide range of clinical presentations,
N. Gulati, C. Allen
semanticscholar +1 more source
Establishment of MOS-SF36 percentile ranks in the general youth French population
BMC Psychology, 2022Background The SF-36 is a generic quality of life questionnaire, massively translated and widely used to obtain physical and mental health status. However, validation work in the French language was carried out over a generation ago.
Arthur Trognon+4 more
doaj +1 more source
Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis
Cell Communication and Signaling, 2022Langerhans cell histiocytosis (LCH) is an inflammatory myeloid malignancy in the “L-group” histiocytosis. Mitogen-activated protein kinase (MAPK) pathway activating mutations are detectable in nearly all LCH lesions. However, the pathogenic roles of MAPK
Xue-min Gao, Jian Li, Xin-xin Cao
doaj +1 more source